Breastfeeding mothers were excluded from the clinical trials conducted for vaccines against SARS-CoV-2. Since the start of the vaccination, some doubts have arisen regarding its compatibility with breastfeeding. The aim of this study was to analyse the presence of anti-SARS-CoV-2 antibodies in breast milk and serum (IgG and IgA) of vaccinated breastfeeding women. The main variables of the observational study were: adverse related events after vaccination and determination of the presence of IgG and IgA isotypes antibodies in serum and in breast milk of vaccinated women against the SARS-CoV-2 antigens. Results: 110 breastfeeding mothers were included; 70 women (63.6%) were vaccinated with two doses of BNT162b2, 20 women (18.2%) with two doses of mRNA-1273, and 20 women (18.2%) with a single dose of ChAdOx1-S. Regarding adverse reactions and vaccine safety, 38 women had no adverse reactions; 20 (18.2%) had general malaise or adenopathies; 10 (9.1%) had a headache; and 7 (6.4%) had fever. When analysing IgG antibodies, significantly higher levels of antibodies were found in serum and breast milk from mothers vaccinated with BNT162b2 or mRNA-1273 vs. ChAdOx1-S ( p < 0.001 and p = 0.001, respectively). Analysing IgA antibodies, significant differences were found when comparing mean values in serum from mothers vaccinated with BNT162b2 or mRNA-1273 vs. ChAdOx1-S (0.12, 0.16, and 0.02, respectively; p < 0.001) and breast milk of mothers vaccinated when comparing BNT16b2 vs. ChAdOx1-S. All vaccinated breastfeeding mothers had serum anti-S1 IgG antibodies in response to vaccination against SARS-CoV-2, regardless of the commercial vaccine administered. Conclusions: the anti-SARS-CoV-2 vaccines were well tolerated by the mothers and the breastfed infant. In addition, breastfeeding mothers offer their infants IgA and IgG isotype antibodies directed against SARS-CoV-2 protein S in breast milk.
【저자키워드】 antibodies, Breastfeeding, COVID-19 vaccine, breast milk, maternal immunity, neonatal immunity, 【초록키워드】 SARS-CoV-2, IgG, Vaccine, vaccination, clinical trial, antibody, mRNA-1273, clinical trials, headache, observational study, Infant, BNT162b2, Adverse reactions, serum, anti-SARS-CoV-2 antibodies, anti-SARS-CoV-2 antibody, IgG antibodies, IgA, mRNA, Fever, breast milk, antigens, women, ChAdOx1, single dose, SARS-CoV-2 antigens, ChAdOx1-S, mother, dose, Adverse reaction, anti-SARS-CoV-2 vaccine, significant difference, significant differences, isotype, IgA antibodies, mean value, malaise, SARS-CoV-2 protein, IgG isotype antibodies, offer, variable, Administered, event, anti-SARS-CoV-2 vaccines, general malaise, addition, conducted, significantly higher, had no, Analysing, anti-S1 IgG antibody, breastfeeding women, IgG isotype antibody, levels of antibody, of BNT162b2, response to vaccination, the SARS-CoV-2, were excluded, 【제목키워드】 SARS-CoV-2, IgG, IgA, Spain, induction, milk,